Lipella Pharmaceuticals Inc.
LIPO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $2,185 | $3,294 | $5,122 | $1,414 |
| Short-Term Investments | $0 | $0 | $0 | $301 |
| Receivables | $85 | $32 | $114 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $348 | $103 | $564 | $94 |
| Total Curr. Assets | $2,617 | $3,429 | $5,799 | $1,808 |
| Property Plant & Equip (Net) | $57 | $148 | $151 | $205 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $57 | $148 | $151 | $205 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,674 | $3,577 | $5,950 | $2,013 |
| Liabilities | – | – | – | – |
| Payables | $388 | $138 | $384 | $47 |
| Short-Term Debt | $48 | $89 | $333 | $65 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $319 | $158 | $461 | $229 |
| Total Curr. Liab. | $754 | $385 | $1,178 | $341 |
| LT Debt | $0 | $47 | $96 | $218 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $30 |
| Total NC Liab. | $0 | $47 | $96 | $249 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $48 | $137 | $155 | $208 |
| Total Liabilities | $754 | $433 | $1,275 | $589 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $1 | $1 | $0 |
| Retained Earnings | -$15,340 | -$10,324 | -$5,705 | -$3,107 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $17,259 | $13,468 | $10,380 | $4,530 |
| Total Equity | $1,919 | $3,144 | $4,676 | $1,424 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $2,674 | $3,577 | $5,950 | $2,013 |
| Net Debt | -$2,137 | -$3,157 | -$4,692 | -$1,131 |